China Biologic Receives Approval to Purchase Raw Supplies Mr. David (Xiaoying) Gao, Chairman and Chief Executive Officer of China Biologic, commented, "With the CFDA's particular approval, this plasma acquire presents a unique development opportunity for China Biologic in the near